Cyrille Leperlier
Director/Board Member bij NUCANA PLC
Vermogen: - $ op 31-03-2024
Profiel
Cyrille Raymond George Leperlier is currently the Chief Executive Officer at Divlal SAS since 2020 and an Independent Non-Executive Director at NuCana Plc since 2018.
Previously, he worked as a Medical Director at Rhone-Poulenc Rorer, Inc. and Sanofi-Aventis Japan from 2004 to 2019, where he held the position of Medical Director from 2014 to 2019.
He obtained a graduate and doctorate degree from the University of Paris Jussieu.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NUCANA PLC
-.--% | 31-12-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Cyrille Leperlier
Bedrijven | Functie | Begin |
---|---|---|
NUCANA PLC | Director/Board Member | 01-05-2018 |
Divlal SAS | Chief Executive Officer | 01-06-2020 |
Eerdere bekende functies van Cyrille Leperlier
Bedrijven | Functie | Einde |
---|---|---|
Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | 01-12-2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Cyrille Leperlier
University of Paris Jussieu | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NUCANA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Sanofi-Aventis Japan | |
Divlal SAS |